[HTML][HTML] DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application

C Hu, X Liu, Y Zeng, J Liu, F Wu - Clinical Epigenetics, 2021 - Springer
DNA methylation, an epigenetic modification, regulates gene transcription and maintains
genome stability. DNA methyltransferase (DNMT) inhibitors can activate silenced genes at …

[HTML][HTML] Curcumin: An epigenetic regulator and its application in cancer

T Ming, Q Tao, S Tang, H Zhao, H Yang, M Liu… - Biomedicine & …, 2022 - Elsevier
Nowadays, one of the leading causes of death in humans is cancer, which is still on the rise
globally and is in great need of intense study on the pathogenic mechanism and effective …

[HTML][HTML] Impact of epigenetic reprogramming on antitumor immune responses in glioma

BL McClellan, S Haase, FJ Nunez… - The Journal of …, 2023 - Am Soc Clin Investig
Epigenetic remodeling is a molecular hallmark of gliomas, and it has been identified as a
key mediator of glioma progression. Epigenetic dysregulation contributes to gliomagenesis …

[HTML][HTML] Non-coding RNAs as prognostic markers for endometrial cancer

R Piergentili, S Zaami, AF Cavaliere, F Signore… - International Journal of …, 2021 - mdpi.com
Endometrial cancer (EC) has been classified over the years, for prognostic and therapeutic
purposes. In recent years, classification systems have been emerging not only based on EC …

[HTML][HTML] Epigenetic regulation of genomic stability by vitamin C

JP Brabson, T Leesang, S Mohammad… - Frontiers in genetics, 2021 - frontiersin.org
DNA methylation plays an important role in the maintenance of genomic stability. Ten-
eleven translocation proteins (TETs) are a family of iron (Fe2+) and α-KG-dependent …

[HTML][HTML] A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer

H Kumar, NV Gupta, R Jain… - Journal of Advanced …, 2023 - Elsevier
Background Triple-negative breast cancer (TNBC) is a heterogeneous, aggressive
phenotype of breast cancer with associated chemoresistance. The development of chemo-or …

Epigenetic regulation of cancer-associated fibroblast heterogeneity

RJ Kehrberg, N Bhyravbhatla, SK Batra… - Biochimica et Biophysica …, 2023 - Elsevier
Abstract Cancer-associated fibroblasts (CAFs), a significant component of the tumor
microenvironment (TME), contribute to cancer progression through the secretion of …

[HTML][HTML] Extracellular vesicles: emerging modulators of cancer drug resistance

F Fontana, E Carollo, GE Melling, DRF Carter - Cancers, 2021 - mdpi.com
Simple Summary Drug resistance still represents the main reason for therapy failure in
cancer patients. In the last decade, extracellular vesicles (EVs), a heterogeneous group of …

Epigenetic enzyme mutations as mediators of anti-cancer drug resistance

S Chen, Y Zhao, S Liu, J Zhang, YG Assaraf… - Drug Resistance …, 2022 - Elsevier
Despite the rapid advancement in the introduction of new drugs for cancer therapy, the
frequent emergence of drug resistance leads to disease progression or tumor recurrence …

[HTML][HTML] Epigallocatechin-3-gallate therapeutic potential in cancer: mechanism of action and clinical implications

M Kciuk, M Alam, N Ali, S Rashid, P Głowacka… - Molecules, 2023 - mdpi.com
Cellular signaling pathways involved in the maintenance of the equilibrium between cell
proliferation and apoptosis have emerged as rational targets that can be exploited in the …